Minute Insight: Are Things Going Pear-Shaped For Digital Therapeutics?
Executive Summary
Pear Therapeutics is restructuring itself to lower costs following repeated disappointing performances.
You may also be interested in...
Pear Therapeutics Obtains First Medicaid Coverage For PDTs
Massachusetts’ Medicaid program will cover reSET and reSET-O prescription digital therapeutics for the treatment of substance abuse disorder and opioid use disorder.
Minute Insight: BellaSeno Starts Trials Of Reconstructive Chest Implants Using Resorbable Material
The company is trialing absorbable implants for both cosmetic and reconstructive surgeries.
Medtech Monthly, Ep. 2: Where Does Diabetes Tech Stand In 2022?
In this edition of Medtech Monthly, Robert Gabbay, chief scientific and medical officer for the American Diabetes Association talked to Medtech Insight about diabetes tech, where it's headed, and what it could mean for preventative care.